相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Alpha-synuclein oligomerization and dopaminergic degeneration occur synchronously in the brain and colon of MPTP-intoxicated parkinsonian monkeys
Xuran Li et al.
NEUROSCIENCE LETTERS (2020)
Pathological remodelling of colonic wall following dopaminergic nigrostriatal neurodegeneration
Carolina Pellegrini et al.
NEUROBIOLOGY OF DISEASE (2020)
Impairment of Nrf2-and Nitrergic-Mediated Gastrointestinal Motility in an MPTP Mouse Model of Parkinson's Disease
C. Sampath et al.
DIGESTIVE DISEASES AND SCIENCES (2019)
Contractile dysfunction and nitrergic dysregulation in small intestine of a primate model of Parkinson's disease
Erika Coletto et al.
NPJ PARKINSONS DISEASE (2019)
Colonic inflammation affects myenteric alpha-synuclein in nonhuman primates
Henry Resnikoff et al.
JOURNAL OF INFLAMMATION RESEARCH (2019)
How Does Parkinson's Disease Begin? Perspectives on Neuroanatomical Pathways, Prions, and Histology
Per Borghammer
MOVEMENT DISORDERS (2018)
Intestinal Pathology and Gut Microbiota Alterations in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Mouse Model of Parkinson's Disease
Feng Lai et al.
NEUROCHEMICAL RESEARCH (2018)
Signaling of free fatty acid receptors 2 and 3 differs in colonic mucosa following selective agonism or coagonism by luminal propionate
Iain R. Tough et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2018)
Ingestion of subthreshold doses of environmental toxins induces ascending Parkinsonism in the rat
L. Anselmi et al.
NPJ PARKINSONS DISEASE (2018)
A Nigro-Vagal Pathway Controls Gastric Motility and Is Affected in a Rat Model of Parkinsonism
Laura Anselmi et al.
GASTROENTEROLOGY (2017)
Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration
C. Pellegrini et al.
NEUROPHARMACOLOGY (2017)
Altered detrusor contractility in MPTP-treated common marmosets with bladder hyperreflexia
Sara Pritchard et al.
PLOS ONE (2017)
Gastrointestinal Dysfunction and Neuropathologic Correlations in Parkinson Disease
Saloua Mrabet et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2016)
Microbiota-gut-brain signalling in Parkinson's disease: Implications for non-motor symptoms
Valeria D. Felice et al.
PARKINSONISM & RELATED DISORDERS (2016)
Enteric Dysfunctions in Experimental Parkinson's Disease: Alterations of Excitatory Cholinergic Neurotransmission Regulating Colonic Motility in Rats
Matteo Fornai et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2016)
Pathogenesis of Parkinson disease-the gut-brain axis and environmental factors
Lisa Klingelhoefer et al.
NATURE REVIEWS NEUROLOGY (2015)
Long-Term Systemic Exposure to Rotenone Induces Central and Peripheral Pathology of Parkinson's Disease in Mice
Shinki Murakami et al.
NEUROCHEMICAL RESEARCH (2015)
Constipation is reduced by beta-blockers and increased by dopaminergic medications in Parkinson's disease
Gennaro Pagano et al.
PARKINSONISM & RELATED DISORDERS (2015)
Causes and Consequences of Degeneration of the Dorsal Motor Nucleus of the Vagus Nerve in Parkinson's Disease
James G. Greene
ANTIOXIDANTS & REDOX SIGNALING (2014)
Gastrointestinal manifestations in Parkinson's disease: prevalence and occurrence before motor symptoms
Maria G. Cersosimo et al.
JOURNAL OF NEUROLOGY (2013)
Colonic inflammation in Parkinson's disease
David Devos et al.
NEUROBIOLOGY OF DISEASE (2013)
Deficiency for the Ubiquitin Ligase UBE3B in a Blepharophimosis-Ptosis-Intellectual-Disability Syndrome
Lina Basel-Vanagaite et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2012)
Intestinal dysmotility and enteric neurochemical changes in a Parkinson's disease rat model
Mario Colucci et al.
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL (2012)
Gastrointestinal Dysfunction in a Parkinson's Disease Rat Model and the Changes of Dopaminergic, Nitric Oxidergic, and Cholinergic Neurotransmitters in Myenteric Plexus
Hong Can Zhu et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2012)
The enteric nervous system and neurogastroenterology
John B. Furness
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2012)
Endogenous peptide YY and neuropeptide Y inhibit colonic ion transport, contractility and transit differentially via Y1 and Y2 receptors
I. R. Tough et al.
BRITISH JOURNAL OF PHARMACOLOGY (2011)
Gastrointestinal Features of Parkinson's Disease
Leslie J. Cloud et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2011)
Etiology and Pathogenesis of Parkinson's Disease
Anthony H. Schapira et al.
MOVEMENT DISORDERS (2011)
Involvement of the peripheral nervous system in synucleinopathies, tauopathies and other neurodegenerative proteinopathies of the brain
Koichi Wakabayashi et al.
ACTA NEUROPATHOLOGICA (2010)
MPTP-induced parkinsonism extends to a subclass of TH-positive neurons in the gut
Gianfranco Natale et al.
BRAIN RESEARCH (2010)
Delayed gastric emptying and enteric nervous system dysfunction in the rotenone model of Parkinson's disease
James G. Greene et al.
EXPERIMENTAL NEUROLOGY (2009)
5-HT4 Receptor-Mediated Neuroprotection and Neurogenesis in the Enteric Nervous System of Adult Mice
Min-Tsai Liu et al.
JOURNAL OF NEUROSCIENCE (2009)
Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment
K. Ray Chaudhuri et al.
LANCET NEUROLOGY (2009)
Neurochemical plasticity in the enteric nervous system of a primate animal model of experimental Parkinsonism
T. Chaumette et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2009)
Functional and neurochemical changes of the gastrointestinal tract in a rodent model of Parkinson's disease
F. Blandini et al.
NEUROSCIENCE LETTERS (2009)
Alpha-synuclein-immunopositive myenteric neurons and vagal preganglionic terminals: Autonomic pathway implicated in Parkinson's disease?
R. J. Phillips et al.
NEUROSCIENCE (2008)
Alteration of dopaminergic markers in gastrointestinal tract of different rodent models of Parkinson's disease
Y. -M. Tian et al.
NEUROSCIENCE (2008)
Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease
Grant Anderson et al.
EXPERIMENTAL NEUROLOGY (2007)
Stanley Fahn Lecture 2005:: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered
Heiko Braak et al.
MOVEMENT DISORDERS (2006)
MPTP treatment of common marmosets impairs proteasomal enzyme activity and decreases expression of structural and regulatory elements of the 26S proteasome
BY Zeng et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2006)
Gastric α-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology
H Braak et al.
NEUROSCIENCE LETTERS (2006)
The regulation of veratridine-stimulated electrogenic ion transport in mouse colon by neuropeptide Y (NPY), Y1 and Y2 receptors
NP Hyland et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease
KSP McNaught et al.
ANNALS OF NEUROLOGY (2004)
Neuropeptide Y, Y-1, Y-2 and Y-4 receptors mediate Y agonist responses in isolated human colon mucosa
HM Cox et al.
BRITISH JOURNAL OF PHARMACOLOGY (2002)
分享论文
